Cleveland BioLabs, Inc. CBLI

Cleveland BioLabs, Inc. DSO Ratio 2011-2026 | CBLI

Annual DSO Ratio Cleveland BioLabs, Inc.

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
16	124	80.8	104	36.6	85.1	26.3	19.7	4.28	72.3

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
124	4.28	56.9

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
ACADIA Pharmaceuticals ACAD	37.5	$ 22.57	0.04 %	$ 3.74 B	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Akebia Therapeutics AKBA	62.9	$ 1.41	-1.4 %	$ 363 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Aravive ARAV	16.8	-	-13.39 %	$ 1.45 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Aytu BioScience AYTU	150	$ 2.56	-3.76 %	$ 16.1 M	USA
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.85	-1.39 %	$ 9.26 B	Australia
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Amphastar Pharmaceuticals AMPH	70.9	$ 20.87	2.3 %	$ 976 M	USA
Aquestive Therapeutics AQST	103	$ 4.17	-0.24 %	$ 446 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Arcutis Biotherapeutics ARQT	106	$ 24.57	-0.16 %	$ 3.13 B	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
CymaBay Therapeutics CBAY	182	-	-	$ 3.45 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Avid Bioservices CDMO	45.6	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	2.26 K	-	-	$ 1.41 B	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 2.93	-4.87 %	$ 6.38 B	Israel
Checkpoint Therapeutics CKPT	6.83	-	-	$ 169 M	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Celldex Therapeutics CLDX	321	$ 33.62	3.73 %	$ 2.23 B	USA
Concert Pharmaceuticals CNCE	147	-	-	$ 401 M	USA
Celsion Corporation CLSN	15.6	-	-6.63 %	$ 13.9 M	USA